This protocol addresses the early phase of complex regional pain syndrome — within the first 18 months from onset — when the affected extremity shows prominent active inflammatory signs. Early-phase CRPS may respond differently to treatment than the persistent, longer-duration form of the condition.
Disease duration up to 18 months, with prominent inflammatory signs of the affected extremity:
Early CRPS (up to 6–18 months duration) can respond differently to interventions than persistent CRPS, and this presentation warrants a specific treatment approach.
Early CRPS (up to 6-18 months duration) can respond differently to interventions than persistent CRPS.
Some evidence (level 2) suggests that very early initiation (after trauma) of steroid treatment (approximately 30 mg/day for 2–12 weeks, followed by a taper) may be effective.
Given the data, a short course of steroids may be indicated in early CRPS with prominent inflammation, but longer courses are unproven and there are numerous, serious contraindications to chronic steroid use.
Many patients may have spontaneous improvement in inflammatory features over time—even those patients whose pain does not get better.